These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials. Zis P; Shafiq F; Mitsikostas DD Seizure; 2017 Feb; 45():95-99. PubMed ID: 27978485 [TBL] [Abstract][Full Text] [Related]
4. Nocebo in motor neuron disease: systematic review and meta-analysis of placebo-controlled clinical trials. Shafiq F; Mitsikostas DD; Zis P Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):576-582. PubMed ID: 28593798 [TBL] [Abstract][Full Text] [Related]
5. Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials. Zis P; Hadjivassiliou M; Sarrigiannis PG; Jenkins TM; Mitsikostas DD J Neurol Sci; 2018 May; 388():79-83. PubMed ID: 29627036 [TBL] [Abstract][Full Text] [Related]
6. Nocebo in clinical trials for depression: a meta-analysis. Mitsikostas DD; Mantonakis L; Chalarakis N Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741 [TBL] [Abstract][Full Text] [Related]
7. Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Mitsikostas DD; Chalarakis NG; Mantonakis LI; Delicha EM; Sfikakis PP Eur J Neurol; 2012 May; 19(5):672-80. PubMed ID: 21973313 [TBL] [Abstract][Full Text] [Related]
8. Nocebo effect in multiple system atrophy: systematic review and meta-analysis of placebo-controlled clinical trials. Wang ZX; Zhang NN; Zhao HX; Song J Neurol Sci; 2022 Feb; 43(2):899-905. PubMed ID: 34973075 [TBL] [Abstract][Full Text] [Related]
9. Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal. Watanabe T; Sieg M; Lunde SJ; Persson M; Taneja P; Baad-Hansen L; Pigg M; Vase L J Oral Rehabil; 2023 Apr; 50(4):332-342. PubMed ID: 36648379 [TBL] [Abstract][Full Text] [Related]
10. Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis. Sung YK; Lee YH Z Rheumatol; 2022 Jun; 81(5):430-437. PubMed ID: 33687525 [TBL] [Abstract][Full Text] [Related]
11. The placebo response in myasthenia gravis assessed by quantitative myasthenia gravis score: A meta-analysis. Frisaldi E; Shaibani A; Vollert J; Ferrero B; Carrino R; Ibraheem HD; Vase L; Benedetti F Muscle Nerve; 2019 Jun; 59(6):671-678. PubMed ID: 30883809 [TBL] [Abstract][Full Text] [Related]
12. Nocebo in cerebellar ataxia: A systematic review and meta-analysis of placebo-controlled clinical trials. Alam JM; Hadjivassiliou M; Zis P J Neurol Sci; 2019 Jun; 401():112-117. PubMed ID: 31075682 [TBL] [Abstract][Full Text] [Related]
13. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature. Zis P; Mitsikostas DD Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057 [TBL] [Abstract][Full Text] [Related]
14. Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Howick J; Webster R; Kirby N; Hood K Trials; 2018 Dec; 19(1):674. PubMed ID: 30526685 [TBL] [Abstract][Full Text] [Related]
15. Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis. Stathis P; Smpiliris M; Konitsiotis S; Mitsikostas DD Eur J Neurol; 2013 Mar; 20(3):527-533. PubMed ID: 23145482 [TBL] [Abstract][Full Text] [Related]
16. Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction. Glissen Brown JR; Sanayei A; Proctor S; Flanagan R; Ballou S; Bain PA; Nee J Am J Gastroenterol; 2023 Apr; 118(4):692-701. PubMed ID: 36563308 [TBL] [Abstract][Full Text] [Related]
17. Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials. Zis P; Shafique F; Hadjivassiliou M; Blackburn D; Venneri A; Iliodromiti S; Mitsikostas DD; Sarrigiannis PG Neuromodulation; 2020 Apr; 23(3):291-300. PubMed ID: 30896060 [TBL] [Abstract][Full Text] [Related]
18. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis. Wang S; Xiong Z; Cui Y; Fan F; Zhang S; Jia R; Hu Y; Li L; Zhang X; Han F Mov Disord; 2024 Mar; 39(3):585-595. PubMed ID: 38247265 [TBL] [Abstract][Full Text] [Related]
19. Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ma C; Panaccione NR; Nguyen TM; Guizzetti L; Parker CE; Hussein IM; Vande Casteele N; Khanna R; Dulai PS; Singh S; Feagan BG; Jairath V J Crohns Colitis; 2019 Sep; 13(9):1201-1216. PubMed ID: 31111881 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies. Chin YH; Lim O; Lin C; Chan YY; Kong G; Ng CH; Chong B; Syn N; Chan KE; Muthiah MD; Siddiqui MS; Wang JW; Figtree G; Chan MY; Chew NWS Eur Heart J Qual Care Clin Outcomes; 2023 Aug; 9(5):511-519. PubMed ID: 36107462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]